-
Something wrong with this record ?
Marine Ligands of the Pregnane X Receptor (PXR): An Overview
A. Carazo, P. Mladěnka, P. Pávek,
Language English Country Switzerland
Document type Journal Article, Review
Grant support
CZ.02.1.01/0.0/0.0/16_019/0000841
European Regional Development Fund
NLK
Directory of Open Access Journals
from 2003
Free Medical Journals
from 2003
PubMed Central
from 2003
Europe PubMed Central
from 2003
ProQuest Central
from 2003-01-01
Open Access Digital Library
from 2003-01-01
Open Access Digital Library
from 2003-01-01
Health & Medicine (ProQuest)
from 2003-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2003
PubMed
31569349
DOI
10.3390/md17100554
Knihovny.cz E-resources
- MeSH
- Biological Products chemistry isolation & purification pharmacology MeSH
- Humans MeSH
- Ligands MeSH
- Molecular Structure MeSH
- Porifera chemistry MeSH
- Pregnane X Receptor metabolism MeSH
- Gene Expression Regulation drug effects MeSH
- Urochordata chemistry MeSH
- Aquatic Organisms chemistry MeSH
- Drug Development * MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
Pregnane X Receptor (PXR) is a ligand-activated transcription factor which binds many structurally different molecules. The receptor is able to regulate the expression of a wide array of genes and is involved in cancer and different key physiological processes such as the metabolism of drugs/xenobiotics and endogenous compounds including lipids and carbohydrates, and inflammation. Algae, sponges, sea squirts, and other marine organisms are some of the species from which structurally new molecules have been isolated that have been subsequently identified in recent decades as ligands for PXR. The therapeutic potential of these natural compounds is promising in different areas and has recently resulted in the registration of trabectedin by the FDA as a novel antineoplastic drug. Apart from being potentially novel drugs, these compounds can also serve as models for the development of new molecules with improved activity. The aim of this review is to succinctly summarize the currently known natural molecules isolated from marine organisms with a proven ability to interact with PXR.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20005845
- 003
- CZ-PrNML
- 005
- 20200526095659.0
- 007
- ta
- 008
- 200511s2019 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/md17100554 $2 doi
- 035 __
- $a (PubMed)31569349
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Carazo, Alejandro $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University, Heyrovského 1203, Hradec Králové 500 05, Czech Republic. carazofa@faf.cuni.cz.
- 245 10
- $a Marine Ligands of the Pregnane X Receptor (PXR): An Overview / $c A. Carazo, P. Mladěnka, P. Pávek,
- 520 9_
- $a Pregnane X Receptor (PXR) is a ligand-activated transcription factor which binds many structurally different molecules. The receptor is able to regulate the expression of a wide array of genes and is involved in cancer and different key physiological processes such as the metabolism of drugs/xenobiotics and endogenous compounds including lipids and carbohydrates, and inflammation. Algae, sponges, sea squirts, and other marine organisms are some of the species from which structurally new molecules have been isolated that have been subsequently identified in recent decades as ligands for PXR. The therapeutic potential of these natural compounds is promising in different areas and has recently resulted in the registration of trabectedin by the FDA as a novel antineoplastic drug. Apart from being potentially novel drugs, these compounds can also serve as models for the development of new molecules with improved activity. The aim of this review is to succinctly summarize the currently known natural molecules isolated from marine organisms with a proven ability to interact with PXR.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a vodní organismy $x chemie $7 D059001
- 650 _2
- $a biologické přípravky $x chemie $x izolace a purifikace $x farmakologie $7 D001688
- 650 12
- $a vyvíjení léků $7 D000076722
- 650 _2
- $a regulace genové exprese $x účinky léků $7 D005786
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a Porifera $x chemie $7 D011161
- 650 _2
- $a pregnanový X receptor $x metabolismus $7 D000077297
- 650 _2
- $a Urochordata $x chemie $7 D014561
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Mladěnka, Přemysl $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University, Heyrovského 1203, Hradec Králové 500 05, Czech Republic. mladenkap@faf.cuni.cz.
- 700 1_
- $a Pávek, Petr $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University, Heyrovského 1203, Hradec Králové 500 05, Czech Republic. pavek@faf.cuni.cz.
- 773 0_
- $w MED00165871 $t Marine drugs $x 1660-3397 $g Roč. 17, č. 10 (2019)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31569349 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200526095655 $b ABA008
- 999 __
- $a ok $b bmc $g 1524703 $s 1095901
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 17 $c 10 $e 20190928 $i 1660-3397 $m Marine drugs $n Mar. drugs $x MED00165871
- GRA __
- $a CZ.02.1.01/0.0/0.0/16_019/0000841 $p European Regional Development Fund
- LZP __
- $a Pubmed-20200511